Closed · CDC-RFA-PS23-0013 · CFDA 93.939 · Discretionary

Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States

Federal grant opportunity posted by Centers for Disease Control - NCHHSTP, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 6, 2023
Close date
1
Expected awards

The verdict

Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States is a closed discretionary listing from Centers for Disease Control - NCHHSTP that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
1
expected award
93.939
CFDA program

Opportunity snapshot. This Grants.gov announcement - Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States - is cataloged under number CDC-RFA-PS23-0013 and tied to CFDA assistance listing 93.939, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on April 5, 2023. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Varies by applicant. The agency has projected $3.8 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $3.8 million estimated pool, the average award works out to roughly $3.8 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on June 6, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

June 6, 2023

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

April 5, 2023

Est. Total Funding

$3,750,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The NOFO supports program activities to achieve and maintain the elimination of perinatal HIV transmission in the United States and to optimize the health and wellbeing of people with HIV, their infants, and all persons with perinatally acquired HIV. The recipient will collaborate with CDC over a 5 year period of performance to establish a National Resource Center for the implementation of CDC’s Framework for the Elimination of Perinatal HIV in the United States and will convene a Task Force of subject matter experts from public health, clinical care and persons living with HIV to develop innovative approaches to optimize perinatal, maternal/parental and infant health for persons affected by HIV. The recipient will also disseminate resources and technical assistance through large educational and best-practice-sharing networks. These activities will result in an increased awareness by clinical and public health professionals of strategies to achieve and maintain elimination of perinatal HIV in the United States as well as approaches to optimize the health of families affected by HIV. The provision of technical assistance and capacity building to improve perinatal HIV care and prevention systems will also create opportunities to utilize aspects of The Framework for the prevention of congenital syphilis or other perinatal infections.In 2012, CDC published a framework for the elimination of perinatal HIV transmission in the United States (The Framework). Based on the latest national data, elimination of perinatal HIV transmission may have occurred in the United States: in 2019, CDC received 32 reports of U.S.-born infants with diagnosed perinatal infection. To maintain low numbers of diagnoses of perinatal HIV each year, and to ensure the short- and long-term safety of perinatal HIV prevention interventions, it will be necessary to build upon past work to implement The Framework. The 6 components of The Framework include: 1) reproductive health, family planning and prepregnancy care services for women of childbearing age with HIV, 2) HIV testing and comprehensive case-finding by public health, 3) assurance of clinical care and behavioral health services for pregnant women with HIV and their infants, 4) continuous quality improvement of local perinatal HIV health systems through a case review and community action process such as the FIMR-HIV methodology, 5) research and long-term monitoring to ensure preventive interventions and contemporary antiretroviral medications are not only efficacious but also safe, and 6) thorough HIV data surveillance to evaluate and direct public health prevention programs.In a previous CDC-funded activity, PS17-1712, an Elimination of Perinatal HIV Task Force comprised of clinical and public health subject matter experts as well as women with HIV identified key issues necessary to maintain gains in perinatal prevention and to optimize the health and wellbeing of women with HIV and their children. Acquisition of HIV during pregnancy from male partners was identified as an ongoing concern, and strategies such as partner HIV testing during pregnancy are needed not only to prevent transmission to pregnant women and children, but also to provide HIV treatment for the health of partners. New strategies to ensure that HIV treatment and preventive interventions are not only effective, but also safe during conception, throughout pregnancy and lactation are needed. In addition, up-to-date, comprehensive, and timely surveillance systems are needed for continuous and vigilant monitoring of the long-term safety of prenatal and early-life antiretroviral exposure. Women with HIV in the United States are increasingly expressing desires to breastfeed their infants, and recommendations in the United States regarding infant feeding for people with HIV are evolving. Developing and disseminating information to support women with HIV and their providers is needed to ensure infant feeding approaches optimize infant and maternal health.As considerations of perinatal HIV transmission evolve in this era, it will be necessary to maintain a public health and clinical workforce capable of dealing with the many issues. This NOFO will support activities that contribute to maintaining the gains in perinatal HIV prevention and perhaps further reduce the annual number of perinatal HIV infections. It also will contribute to improvements in maternal, paternal and child health along the HIV prevention and care continuums.If additional funds become available, this NOFO will provide opportunities to share infrastructure and resources with health care providers and public health professionals to utilize similar approaches to reduce other congenital or perinatal infections, including congenital syphilis, in the United States.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 06, 07, 11, 12, 13, 20, 22, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Margaret A. Lampe, Project Officer MLampe@cdc.gov

Key Dates

Posted April 5, 2023
Close Date June 6, 2023
Archive Date July 4, 2023
Last Updated April 5, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States", offered by Centers for Disease Control - NCHHSTP. It is associated with CFDA program 93.939. The NOFO supports program activities to achieve and maintain the elimination of perinatal HIV transmission in the United States and to optimize the health and wellbeing of people with HIV, their infan...
Is this opportunity still open?
No, this opportunity is closed. It closed on June 6, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $3,750,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants